Article
Fewer Checks, Bigger Stakes: Reduced Deal Volume And Shifting Terms Reshape Mid-Market Life Sciences VC In 2026
The opening quarter of 2026 brought a noticeable cooling in mid-market life sciences venture activity, with deal volume dropping significantly from prior periods.
Foley Hoag LLP